GPCR in the 13F filings
Structure Therapeutics Inc · CUSIP 86366E106
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 14 Aug 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 19
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 4 listed it in both
- Shares listed
- 23,457,247
- combined, among listed positions
- Reported value
- $1.3bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 9 buyers (opened or added shares) and 14 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -2,211,238.
Managers listing GPCR in Q2 2026
19 of 19 holders
Largest increases and reductions, by shares
Increases
- Marshall Wace LLPexisting position · 267,592 shares now+198,485
- Wellington Management Group LLPexisting position · 7,379,433 shares now+119,146
- Squarepoint Ops LLCexisting position · 125,575 shares now+102,929
- ExodusPoint Capital Management LPnew position · 78,266 shares now+78,266
- Susquehanna International Group LLPexisting position · 122,344 shares now+66,502
Reductions
- T. Rowe Price Associates Incexisting position · 845,532 shares now-1,155,164
- Fidelity (FMR LLC)existing position · 7,810,306 shares now-593,143
- Janus Henderson Group Ltdexisting position · 5,204,212 shares now-150,769
- Voloridge Investment Management LLCexisting position · 112,300 shares now-142,669
- D. E. Shaw & Co.existing position · 115,300 shares now-89,490
New positions and exits
New (1)
Exited (4)
- Balyasny Asset Management LLCwas $15m
- Holocene Advisors LPwas $7.7m
- Renaissance Technologies LLCwas $2.7m
- Walleye Capital LLCwas $1.0m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2023 | 1 | $4.0m | n.a. | n.a. |
| Q2 2023 | 2 | $25m | n.a. | n.a. |
| Q3 2023 | 7 | $307m | n.a. | n.a. |
| Q4 2023 | 5 | $314m | 4 | 1 |
| Q1 2024 | 5 | $439m | 4 | 0 |
| Q2 2024 | 8 | $603m | 7 | 1 |
| Q3 2024 | 5 | $738m | 4 | 1 |
| Q4 2024 | 4 | $429m | 4 | 0 |
| Q1 2025 | 3 | $258m | 2 | 1 |
| Q2 2025 | 3 | $244m | 2 | 2 |
| Q3 2025 | 2 | $284m | 0 | 2 |
| Q4 2025 | 7 | $1.5bn | 16 | 10 |
| Q1 2026 | 5 | $636m | 16 | 10 |
| Q2 2026 | 3 | $686m | 9 | 14 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
GPCR and LLY →GPCR and JNJ →GPCR and VRTX →Choose a stock to compare with GPCR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own GPCR, latest filings →Back to the 13F Explorer →